To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Evotec and Harvard University to collaborate on development of new class of antibacterials
17-05-2013
Evotec AG announced a research collaboration with Harvard University aimed at discovering and developing novel anti-bacterial agents based on a highly validated target family involved in bacterial cell wall biosynthesis. Under the Agreement, researchers at Harvard and Evotec will ...
Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
16-05-2013
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ...
Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
16-05-2013
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency ...
Frost & Sullivan commends Merck Serono for its excellence in product differentiation
16-05-2013
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and ...
SYGNIS reports results for the first quarter of 2013
16-05-2013
SYGNIS Pharma AG announced its financial results according to IFRS for the first quarter of 2013, ending 31 March 2013. In the first quarter of 2013, revenues amounted to €0.1 million; operating expenses amounted to €1.3 million. Operating expenses include sales, general & administrative ...
ZEISS presents half-year financial figures
15-05-2013
During the first six months of fiscal year 2012/13 the business trend in the ZEISS Group was marked by the difficult conditions experienced in some markets. Nevertheless, the Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six months ...
Serotonin mediates exercise-induced generation of new neurons
14-05-2013
Mice that exercise in running wheels exhibit increased neurogenesis in the brain. Crucial to this process is serotonin signaling. These are the findings of a study by Dr. Friederike Klempin, Daniel Beis and Dr. Natalia Alenina from the research group led by Professor Michael Bader at the Max ...
Experience leads to the growth of new brain cells
A new study examines how individuality develops
13-05-2013
How do organisms evolve into individuals that are distinguished from others by their own personal brain structure and behaviour? Scientists in Dresden, Berlin, Münster, and Saarbrücken have now taken a decisive step towards clarifying this question. Using mice as an animal model, they were ...
Analytik Jena to develop products for sepsis diagnostics
All assets taken over from insolvent company SIRS-Lab GmbH
08-05-2013
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ...
Analytik Jena AG establishes subsidiary in Thailand
07-05-2013
Analytik Jena AG has established a new subsidiary, Analytik Jena Far East (Thailand) Ltd., giving it a presence in the Southeast Asian market. Analytik Jena AG is using this new company to bolster its activities in the Southeast Asian market, increase its regional service for the sales ...
Netmeeting
